Sign in
4

Changes in Ownership

Damora Therapeutics, Inc. Filed Acc 0001193125-26-006723

Chief Medical Officer acquired 264,629 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Hewes L. Becker Chief Medical Officer 2026-01-05 Grant or award +264,629 264,629 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Hewes L. Becker Chief Medical Officer 2026-01-05 Grant or award · Stock Option (right to buy) +528,603 528,603 D: show line 2 in the form
Loading xslF345X05/ownership.xml…